Cyanvac

0 followers


Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.

Industries

+1

Headquarters

Links

Org chart

Fred C. Davison
Chief Executive Officer

Fred C. Davison

Collapse
Gary Titus
Chief Financial Officer
Hong Jin
Chief Scientific Officer
Marinka Tellier
Chief Regulatory Officer
Samuel Wu
Chief Business Officer